Multipharma
0866.855.346 · rovalta.com · 09/11/2026
Multipharma
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOMultipharma is a Cooperative society incorporated in 2004. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Anderlecht. It employs on average 1 522,8 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0866.855.346
- Incorporation
- 19/08/2004
- Legal form
- Cooperative society
- Registered office
- Square Marie Curie 30
1070 Anderlecht · BruxellesSee on map - Contributed capital
- 104 262 664,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 1 522,8 ETP
Joint committees (2)
- 313
- 321
Financials
Source · NBB, 24 filingsTrend over 18 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 580,8 M € | +5.7% | 549,7 M € | +6.3% | 517,1 M € | +5.5% | 490 M € | +3.6% | 472,9 M € |
| EBITDA | 10,8 M € | -4.0% | 11,2 M € | -14.7% | 13,2 M € | -35.5% | 20,4 M € | -5.2% | 21,6 M € |
| Operating result | -250,4 k € | -117% | 1,5 M € | -40.5% | 2,4 M € | -74.5% | 9,6 M € | -17.4% | 11,6 M € |
| Net result | -2,9 M € | -249% | -819,2 k € | -215% | 712,9 k € | -85.8% | 5 M € | -30.1% | 7,2 M € |
| Balance sheet | |||||||||
| Equity | 128,1 M € | +33.8% | 95,7 M € | -0.8% | 96,5 M € | +0.6% | 96 M € | +6.1% | 90,4 M € |
| Total assets | 274,3 M € | +45.5% | 188,5 M € | -2.2% | 192,8 M € | -0.0% | 192,8 M € | +2.7% | 187,8 M € |
| Cash | 27,9 M € | +110% | 13,3 M € | -27.6% | 18,3 M € | -22.8% | 23,8 M € | +33.2% | 17,8 M € |
| Debts | 139,4 M € | +59.8% | 87,2 M € | -3.2% | 90,1 M € | +0.5% | 89,7 M € | -1.1% | 90,6 M € |
| Other | |||||||||
| Workforce | 1 522,8 ETP | +1.1% | 1 505,8 ETP | -0.7% | 1 517,1 ETP | -0.9% | 1 531,1 ETP | +0.5% | 1 523,1 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20256 active · 7 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Jimmy SCHEVERNELS | Director08/06/2017 → 08/06/2028 | ||
Johan DEKENS | Director14/06/2018 → 08/06/2028 | ||
Martine MAGNEE | Director10/11/2015 → 08/06/2028 | ||
Michel LUTTGENS | Chairman of the board of directors12/06/2025 → 08/06/2028 | ||
Geert REYNIERS | Managing director01/01/2021 → 10/06/2027 | ||
Hans HEYNDELS | Director01/01/2021 → 10/06/2027 |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Francis COLARIS | Chairman of the board of directors01/01/2021 → 2024 accounts | ||
Hilde VERNAILLEN | Chairman of the board of directors14/06/2019 → 2020 accounts |
Other companies at this address
Square Marie Curie 30 1070 Anderlecht| Company | CBE no. |
|---|---|
APOTEEK HANCOUR● Active | 0404.302.136 |
Apoteek Jespers - Cuijpers● Active | 0440.256.175 |
APOTEEK P. Sergeant● Active | 0454.105.203 |
APOTHEEK VANDYCK● Active | 0458.570.666 |
APOTHEEK VUNCKX-PEETERS● Active | 0897.964.137 |
DE ZEVEN HOEKEN● Active | 0461.480.369 |
DLA● Active | 0639.768.151 |
Goed Aalter● Active | 0808.051.471 |
HANCOUR PHARMAPLUS● Active | 0736.781.217 |
HANCOUR PHARMASERVICE● Active | 0806.261.921 |
MULTIPHARMA GROUP● Active | 0401.995.516 |
| 0406.518.090 | |
Popelin Apotheken● Active | 1004.967.609 |
TALPA FARMA● Active | 0686.929.353 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 14/10/2026 | 23/06/2025 | 30/12/2024 | 02/08/2023 | 22/06/2022 | 11/08/2021 |
| General meeting | 11/06/2026 | 12/06/2025 | 13/06/2024 | 08/06/2023 | 09/06/2022 | 10/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 24 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full modelCorrection | 31/12/2025 | 11/06/2026 | 14/10/2026 | French | |
| Full model | 31/12/2025 | 11/06/2026 | 25/06/2026 | French | |
| Full model | 31/12/2024 | 12/06/2025 | 23/06/2025 | French | |
| Full modelCorrection | 31/12/2023 | 13/06/2024 | 30/12/2024 | French | |
| Full model | 31/12/2023 | 13/06/2024 | 17/07/2024 | French | |
| Full model | 31/12/2022 | 08/06/2023 | 02/08/2023 | French | |
| Full model | 31/12/2021 | 09/06/2022 | 22/06/2022 | French | |
| Full model | 31/12/2020 | 10/06/2021 | 11/08/2021 | French | |
| Full modelCorrection | 31/12/2019 | 11/06/2020 | 27/10/2020 | French | |
| Full model | 31/12/2019 | 11/06/2020 | 02/07/2020 | French | |
| Full modelCorrection | 31/12/2018 | 13/06/2019 | 27/08/2019 | French | |
| Full model | 31/12/2018 | 13/06/2019 | 27/06/2019 | French | |
| Full model | 31/12/2017 | 14/06/2018 | 13/07/2018 | French | |
| Full model | 31/12/2016 | 08/06/2017 | 20/06/2017 | French | |
| Full model | 31/12/2015 | 09/06/2016 | 16/06/2016 | French | |
| Full model | 30/06/2015 | 07/10/2015 | 20/10/2015 | French | |
| Abridged model | 30/06/2014 | 01/08/2014 | 11/08/2014 | French | |
| Abridged model | 30/06/2013 | 07/12/2013 | 10/12/2013 | French | |
| Abridged model | 30/06/2012 | 01/12/2012 | 03/12/2012 | French | |
| Abridged model | 30/06/2011 | 16/12/2011 | 04/01/2012 | French | |
| Abridged model | 30/06/2010 | 04/12/2010 | 06/12/2010 | French | |
| Abridged model | 30/06/2009 | 05/12/2009 | 07/12/2009 | French | |
| Abridged model | 30/06/2008 | 06/12/2008 | 08/12/2008 | French | |
| Abridged model | 30/06/2007 | 01/12/2007 | 13/12/2007 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 50 M€ and 100 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20256 active · 7 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Jimmy SCHEVERNELS | Director08/06/2017 → 08/06/2028 | ||
Johan DEKENS | Director14/06/2018 → 08/06/2028 | ||
Martine MAGNEE | Director10/11/2015 → 08/06/2028 | ||
Michel LUTTGENS | Chairman of the board of directors12/06/2025 → 08/06/2028 | ||
Geert REYNIERS | Managing director01/01/2021 → 10/06/2027 | ||
Hans HEYNDELS | Director01/01/2021 → 10/06/2027 |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Francis COLARIS | Chairman of the board of directors01/01/2021 → 2024 accounts | ||
Hilde VERNAILLEN | Chairman of the board of directors14/06/2019 → 2020 accounts |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates23/06/2026ONTSLAGEN - BENOEMINGEN
- Mandates23/06/2026DEMISSIONS, NOMINATIONS
- Restructuring21/10/2025RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Restructuring21/10/2025RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Restructuring26/08/2025RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...) - DIVERSEN
- Restructuring26/08/2025RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...) - DIVERS
- Mandates03/07/2025ONTSLAGEN - BENOEMINGEN
- Mandates03/07/2025DEMISSIONS, NOMINATIONS
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Square Marie Curie 30, 1070 AnderlechtCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00559826 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| MultipharmaCurrent | accounts 2015 → 2025 | Accounts 2025 · 2026-00559826 |
| PHARMACIE GRANDJEAN | accounts 2008 → 2015 | Accounts 2015 · 2015-65500045 |
Events
- 2025Annual accounts 2025-2,9 M €↓
- 12/06/2025nominationMichel LÜTTGENS · administrateur
- 12/06/2025reconductionMartine MAGNEE · administrateur
- 12/06/2025reconductionJohan DEKENS · administrateur
- 12/06/2025reconductionJimmy SCHEVERNELS · administrateur
- 12/06/2025reconductionKPMG Réviseurs d'Entreprises SRL · Commissaire
- 12/06/2025nominationMichel LÜTTGENS · bestuurder
- 12/06/2025reconductionMartine MAGNEE · bestuurder
- 12/06/2025reconductionJohan DEKENS · bestuurder
- 12/06/2025reconductionJimmy SCHEVERNELS · bestuurder
- 12/06/2025reconductionKPMG Bedrijfsrevisoren BV · commissaris
- 04/02/2025nominationGeert REYNIERS · Gedelegeerd bestuurder
- 04/02/2025nominationAlain BOGAERT · mandataris (Finance & Administration Directeur)
- 04/02/2025nominationCindy DEWITTE · mandataris (Human Resources Directeur)
- 04/02/2025nominationJean MAGGIORDOMO · mandataris (Pharmacy Operations Directeur)
- 04/02/2025nominationRiad BELGUENANI · mandataris
- 04/02/2025nominationGrégory STENMANS · mandataris
- 04/02/2025nominationJean VANDENBUSSCHE · mandataris
- 2024Annual accounts 2024-819,2 k €↓
- 24/10/2024nominationDelphine HAHAJI · membre du Comité de direction
- 24/10/2024nominationDelphine HAJAJI · lid van het directiecomité
- 13/06/2024reconductionGeert REYNIERS · bestuurder
- 13/06/2024reconductionHans HEYNDELS · bestuurder
- 13/06/2024reconductionGeert REYNIERS · administrateur
- 13/06/2024reconductionHans HEYNDELS · administrateur
- 01/01/2024reconductionGeert REYNIERS · Administrateur délégué
- 01/01/2024nominationFrancis COLARIS · Président du Conseil d'administration
- 2023Annual accounts 2023712,9 k €↓
- 19/10/2023nominationGeert REYNIERS · Administrateur délégué
- 19/10/2023nominationAlain BOGAERT · Mandataire
- 19/10/2023nominationCindy DEWITTE · Mandataire
- 19/10/2023nominationJean MAGGIORDOMO · Mandataire
- 19/10/2023nominationRiad BELGUENANI · Mandataire
- 19/10/2023nominationGrégory STENMANS · Mandataire
- 19/10/2023nominationRomain COLA · Mandataire
- 19/10/2023nominationGeert REYNIERS · Gedelegeerd bestuurder
- 19/10/2023nominationAlain BOGAERT · Mandataris
- 19/10/2023nominationCindy DEWITTE · Mandataris
- 19/10/2023nominationJean MAGGIORDOMO · Mandataris
- 19/10/2023nominationRiad BELGUENANI · Mandataris
- 19/10/2023nominationGrégory STENMANS · Mandataris
- 19/10/2023nominationRomain COLA · Mandataris
- 08/06/2023nominationGeert REYNIERS · Gedelegeerd bestuurder
- 08/06/2023nominationAlain BOGAERT · Mandataris
- 08/06/2023nominationCindy DEWITTE · Mandataris
- 08/06/2023nominationJean MAGGIORDOMO · Mandataris
- 08/06/2023nominationRiad BELGUENANI · Mandataris
- 08/06/2023nominationGrégory STENMANS · Mandataris
- 08/06/2023nominationPascale TRICOT · Mandataris
- 08/06/2023nominationGeert REYNIERS · Administrateur délégué
- 08/06/2023nominationAlain BOGAERT · Mandataire
- 08/06/2023nominationCindy DEWITTE · Mandataire
- 08/06/2023nominationJean MAGGIORDOMO · Mandataire
- 08/06/2023nominationRiad BELGUENANI · Mandataire
- 08/06/2023nominationGrégory STENMANS · Mandataire
- 08/06/2023nominationPascale TRICOT · Mandataire
- 06/04/2023nominationGeert REYNIERS · Gedelegeerd bestuurder
- 06/04/2023nominationAlain BOGAERT · Mandataris
- 06/04/2023nominationCindy DEWITTE · Mandataris
- 06/04/2023nominationJean MAGGIORDOMO · Mandataris
- 06/04/2023nominationNisrine BOUCHRIT · Mandataris
- 06/04/2023nominationGrégory STENMANS · Mandataris
- 06/04/2023nominationPascale TRICOT · Mandataris
- 06/04/2023nominationGeert REYNIERS · Administrateur délégué
- 06/04/2023nominationAlain BOGAERT · Mandataire
- 06/04/2023nominationCindy DEWITTE · Mandataire
- 06/04/2023nominationJean MAGGIORDOMO · Mandataire
- 06/04/2023nominationNisrine BOUCHRIT · Mandataire
- 06/04/2023nominationGrégory STENMANS · Mandataire
- 06/04/2023nominationPascale TRICOT · Mandataire
- 2022Annual accounts 20225 M €↓
- 09/06/2022reconductionFrancis COLARIS · bestuurder
- 09/06/2022reconductionJohan DEKENS · bestuurder
- 09/06/2022reconductionMartine MAGNEE · bestuurder
- 09/06/2022reconductionJimmy SCHEVERNELS · bestuurder
- 09/06/2022nominationAxel Jorion · commissaris (vaste vertegenwoordiger)
- 09/06/2022reconductionFrancis COLARIS · administrateur
- 09/06/2022reconductionJohan DEKENS · administrateur
- 09/06/2022reconductionMartine MAGNEE · administrateur
- 09/06/2022reconductionJimmy SCHEVERNELS · administrateur
- 09/06/2022nominationKPMG Réviseurs d Entreprises SRL · Commissaire
- 24/03/2022nominationGeert REYNIERS · Administrateur délégué
- 24/03/2022nominationAlain BOGAERT · Mandataire
- 24/03/2022nominationCindy DEWITTE · Mandataire
- 24/03/2022nominationJean MAGGIORDOMO · Mandataire
- 24/03/2022nominationIsmaël BOLSONI SIBILA · Mandataire
- 24/03/2022nominationGrégory STENMANS · Mandataire
- 24/03/2022nominationPascale TRICOT · Mandataire
- 24/03/2022nominationGeert REYNIERS · Bestuurder
- 24/03/2022nominationAlain BOGAERT · Mandataris
- 24/03/2022nominationCindy DEWITTE · Mandataris
- 24/03/2022nominationJean MAGGIORDOMO · Mandataris
- 24/03/2022nominationIsmaël BOLSONI SIBILA · Mandataris
- 24/03/2022nominationGrégory STENMANS · Mandataris
- 24/03/2022nominationPascale TRICOT · Mandataris
- 2021Annual accounts 20217,2 M €↑
- 2020Annual accounts 20202,9 M €↑
- 2019Annual accounts 2019-6 M €↓
- 2018Annual accounts 20182,7 M €↑
- 2017Annual accounts 2017-50,8 M €↓
- 2015Annual accounts 20151 €↓
- 2015Name changeMultipharma
- 2015Annual accounts 201512,7 k €↑
- 2014Annual accounts 2014-26,9 k €↓
- 2013Annual accounts 2013-15,2 k €↑
- 2012Annual accounts 2012-15,2 k €↑
- 2011Annual accounts 2011-22,6 k €↓
- 2010Annual accounts 2010-9 k €↑
- 2009Annual accounts 2009-9,2 k €↓
- 2008Annual accounts 20088,2 k €
- 19/08/2004IncorporationCooperative society